IL314472A - Product purification methods - Google Patents

Product purification methods

Info

Publication number
IL314472A
IL314472A IL314472A IL31447224A IL314472A IL 314472 A IL314472 A IL 314472A IL 314472 A IL314472 A IL 314472A IL 31447224 A IL31447224 A IL 31447224A IL 314472 A IL314472 A IL 314472A
Authority
IL
Israel
Prior art keywords
purifying
methods
product
Prior art date
Application number
IL314472A
Other languages
English (en)
Hebrew (he)
Inventor
Andreas Sebastian Zurbriggen
Carole In-Albon
Original Assignee
Kodiak Sciences Inc
Andreas Sebastian Zurbriggen
In Albon Carole
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kodiak Sciences Inc, Andreas Sebastian Zurbriggen, In Albon Carole filed Critical Kodiak Sciences Inc
Publication of IL314472A publication Critical patent/IL314472A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/22—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/244—Interleukins [IL]
    • C07K16/248—IL-6
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/31—Immunoglobulins specific features characterized by aspects of specificity or valency multispecific
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C07K2317/565—Complementarity determining region [CDR]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IL314472A 2022-02-10 2023-02-09 Product purification methods IL314472A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202263267810P 2022-02-10 2022-02-10
PCT/US2023/062322 WO2023154822A2 (en) 2022-02-10 2023-02-09 Methods of purifying a product

Publications (1)

Publication Number Publication Date
IL314472A true IL314472A (en) 2024-09-01

Family

ID=87521638

Family Applications (1)

Application Number Title Priority Date Filing Date
IL314472A IL314472A (en) 2022-02-10 2023-02-09 Product purification methods

Country Status (10)

Country Link
US (1) US20230250133A1 (cg-RX-API-DMAC7.html)
EP (1) EP4476237A2 (cg-RX-API-DMAC7.html)
JP (1) JP2025505696A (cg-RX-API-DMAC7.html)
KR (1) KR20240142564A (cg-RX-API-DMAC7.html)
CN (1) CN119032099A (cg-RX-API-DMAC7.html)
AU (1) AU2023217074A1 (cg-RX-API-DMAC7.html)
CA (1) CA3251000A1 (cg-RX-API-DMAC7.html)
IL (1) IL314472A (cg-RX-API-DMAC7.html)
MX (1) MX2024009755A (cg-RX-API-DMAC7.html)
WO (1) WO2023154822A2 (cg-RX-API-DMAC7.html)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2819217T3 (es) 2013-09-08 2021-04-15 Kodiak Sciences Inc Conjugados de polímeros iónicos dipolares y factor VIII
CA3059938A1 (en) 2017-04-14 2018-10-18 Kodiak Sciences Inc. Complement factor d antagonist antibodies and conjugates thereof
CA3092588A1 (en) 2018-03-02 2019-09-06 Kodiak Sciences Inc. Il-6 antibodies and fusion constructs and conjugates thereof
CA3157509A1 (en) 2019-10-10 2021-04-15 Kodiak Sciences Inc. Methods of treating an eye disorder
AU2021377336A1 (en) * 2020-11-16 2023-07-06 Prothera Biologics, Inc. Methods for purifying inter-alpha inhibitor proteins
EP4788450A1 (en) * 2023-10-04 2026-08-12 Sartorius BIA Separations d.o.o. Enhanced chromatographic separations of components in a mixture by employing chaotropic elution
WO2025184423A1 (en) * 2024-02-29 2025-09-04 Kodiak Sciences Inc. Cell-surface-targeting-domain-polymer-payload conjugate
US20260070966A1 (en) * 2024-09-06 2026-03-12 Eyebiotech Limited Multivalent fzd4, wnt co-receptor, and vegf receptor molecules and uses thereof
US20260092125A1 (en) * 2024-09-06 2026-04-02 Eyebiotech Limited Multivalent fzd4, wnt co-receptor, and vegf binding molecules and uses thereof
WO2026075981A1 (en) * 2024-10-01 2026-04-09 Regeneron Pharmaceuticals, Inc. Methods of analyzing heterodimeric proteins
CN119454939A (zh) * 2024-11-28 2025-02-18 北海康成(苏州)生物制药有限公司 一种欧莫扑拜单抗原液及其制备方法
CN119524125A (zh) * 2024-11-28 2025-02-28 北海康成(苏州)生物制药有限公司 一种欧莫扑拜单抗原液的生产方法及欧莫扑拜单抗原液

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7045314B2 (en) * 2000-04-04 2006-05-16 Baxter International Inc. Method for the production of bacterial toxins
CN102395597A (zh) * 2009-03-11 2012-03-28 惠氏有限责任公司 纯化小模块免疫药物蛋白的方法
CA2853358A1 (en) * 2011-10-24 2013-05-02 Halozyme, Inc. Companion diagnostic for anti-hyaluronan agent therapy and methods of use thereof
WO2015101586A1 (en) * 2014-01-03 2015-07-09 F. Hoffmann-La Roche Ag Bispecific anti-hapten/anti-blood brain barrier receptor antibodies, complexes thereof and their use as blood brain barrier shuttles
CN110981957B (zh) * 2014-01-15 2024-12-24 豪夫迈·罗氏有限公司 具有改善的蛋白A结合作用的Fc区变体
EP3054007A1 (en) * 2015-02-09 2016-08-10 Institut National De La Sante Et De La Recherche Medicale (Inserm) Recombinant adeno-associated virus particle purification comprising an immuno-affinity purification step
JP6959912B2 (ja) * 2015-09-23 2021-11-05 ジェネンテック, インコーポレイテッド 抗vegf抗体の最適化変異体
IL290457B2 (en) * 2015-12-30 2025-02-01 Kodiak Sciences Inc Antibodies and their conjugates
CA3092588A1 (en) * 2018-03-02 2019-09-06 Kodiak Sciences Inc. Il-6 antibodies and fusion constructs and conjugates thereof
US20210254073A1 (en) * 2020-02-04 2021-08-19 Cornell University Methods for capture and analysis of macromolecular complexes

Also Published As

Publication number Publication date
JP2025505696A (ja) 2025-02-28
AU2023217074A1 (en) 2024-08-15
EP4476237A2 (en) 2024-12-18
MX2024009755A (es) 2024-08-20
CN119032099A (zh) 2024-11-26
WO2023154822A3 (en) 2023-09-21
WO2023154822A8 (en) 2024-04-04
WO2023154822A2 (en) 2023-08-17
KR20240142564A (ko) 2024-09-30
CA3251000A1 (en) 2023-08-17
US20230250133A1 (en) 2023-08-10

Similar Documents

Publication Publication Date Title
GB202001121D0 (en) Process for there synthesis of buprenorphine
NO20190144A1 (en) A process for production of aluminium
GB202202060D0 (en) Product
GB202211033D0 (en) Purification process
GB202403366D0 (en) Product
PT4172136T (pt) Método de purificação de metanol bruto
GB202214771D0 (en) Oral product
GB202214775D0 (en) Oral product
GB202214803D0 (en) Oral product
IL326885A (en) A process for purification of risdiplam
GB202105882D0 (en) A synthesis method of saxagliptin intermediate
HK40100763A (zh) 截短侧耳素的纯化方法
CA3292747A1 (en) A process for purification of ethofumesate
ZA202105424B (en) A method of producing a high protein product
GB202306624D0 (en) Pelletisation of a mineral product
GB202511650D0 (en) Product
GB202511281D0 (en) Product
GB202510313D0 (en) Product
GB202508503D0 (en) Product
GB202507678D0 (en) Product
GB202506897D0 (en) Product
GB202416248D0 (en) Purification process
GB202418716D0 (en) Product
GB202417304D0 (en) Product
GB202416974D0 (en) Product